
Lillian Smart contracted Naegleria fowleri after swimming in Lake Claiborne
AI-generated summary
Naegleria fowleri is a rare amoeba found in warm freshwater that causes primary amebic meningoencephalitis. It is not found in salt water or properly chlorinated pools.
An eight-year-old Louisiana girl has died after contracting a rare, typically fatal brain-eating amoeba after a swim in Lake Claiborne.
Lillian Smart, of Ruston, died on Saturday, one day after celebrating her birthday, her family announced in a public Facebook post on the “Love for Lillian” page.
“Last night Lillian ran from our arms to the arms of Jesus,” her family said in the post. “The injuries to her brain were too severe for her little body to recover from. Everyone did everything they could to keep her here. We are heartbroken and honestly do not know what to do next. How do we put one foot in front of the other without our girl?”
The Louisiana department of health confirmed on 19 August that a state resident had been infected with Naegleria fowleri and said the exposure most likely occurred while the person was swimming in Lake Claiborne in Claiborne parish. Family friends later identified Lillian as the infected resident, according to reports from several local media outlets.
Naegleria fowleri infections are almost always fatal.
Lillian had been hospitalized since 15 August, KNOE reported. As her family faced the crisis, more than two dozen businesses in Ruston showed support and donated a portion of sales to the Smart family, according to the Facebook page.
Naegleria fowleri infections are extremely rare, with only a handful occurring in Louisiana since 2011.
The amoeba flourishes in warm water and is most commonly found in southern states during the summer. Only about 180 cases have been identified in the US since 1937, according to the Centers for Disease Control and Prevention.
In 2023, an Arkansas child died after contracting Naegleria fowleri from a country club splash pad in the state capital of Little Rock.
Naegleria fowleri can be found in warm freshwater across the country, including lakes, rivers and ponds. It is not found in salt water or in swimming pools that are properly maintained and chlorinated.
Experts say the climate crisis is causing the amoeba to pop up in parts of the US where it isn’t typical, such as the north and west. It is likely to cause primary amebic meningoencephalitis, a brain infection that can develop when contaminated water enters the nose and the amoeba travels to the brain.
People cannot become infected just by swallowing water containing Naegleria fowleri, and the infection does not spread from one person to another.

Gaza's healthcare system faces a silent collapse as displacement camps lack basic medical services. Medics report widespread chronic and infectious diseases among the homeless, exacerbated by the destruction of infrastructure and the limited operational capacity of UNRWA.

Rising drug prices and supply shortages in Iran are forcing patients to delay or abandon critical treatments. Economic instability, currency devaluation, and banking restrictions linked to sanctions have severely impacted access to essential medicines.

The Ebola outbreak in the DRC has reached 5,515 confirmed cases and 2,642 deaths. With 51 new cases in Ituri and North Kivu, the WHO and Pope Leo are urging increased international support to contain the virus, which now has a 48 percent fatality rate.

King Harald of Norway, 89, remains hospitalized in Oslo after his health deteriorated over the weekend due to a bacterial infection. The monarch, who is receiving antibiotic treatment, has canceled upcoming official duties while Crown Prince Haakon acts as regent.
Medical experts have raised concerns regarding President Donald Trump's health following a 23-pound weight gain over three years. While the White House maintains the president remains sharp and energetic, doctors emphasize the need for dietary intervention to mitigate obesity risks.

Recent data suggests a potential decline in US obesity prevalence for the first time in over a decade, with experts pointing to the increased use of GLP-1 weight-loss medications like Ozempic and Wegovy as a possible, though unproven, contributing factor.